Change in volumetric tumor growth rate after cytotoxic therapy is predictive of overall survival in recurrent glioblastoma is a research paper published in Neuro-Oncology Advances (2023). On theSindex it has a DataRank of 0.330. It has been cited 8 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: R01CA270027
National Institutes of Health
Grant: R01CA279984
National Institutes of Health
Grant: P50CA211015
National Institutes of Health
Grant: NIGMS T32 GM008042
National Institutes of Health
Grant: 5R01CA270027-02
Role of decorin and diffusion MRI in anti-VEGF efficacy for recurrent glioblastoma
Wellcome Trust
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5T32GM008042-27
Medical Scientist Training Program
National Institutes of Health
Grant: 5P50CA211015-02
UCLA SPORE in Brain Cancer
National Institutes of Health
Grant: 5R01CA279984-03
Quantitative molecular MR-PET imaging of glycolysis in glioblastoma
FWCI
1.31
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals